Possibilities of multi-parameter ultrasonography in diagnostic and evaluation of Vitex agnus-castus treatment of patients with mastodynia and mastopathy

Authors

DOI:

https://doi.org/10.18370/2309-4117.2023.67.47-54

Keywords:

elastography of mammary glands, ultrasonography, prolactin, hyperprolactinemia, mastodynia, mastopathy, Vitex agnus-castus

Abstract

Objectives: 1) to determine the elasticity of normal breast tissue (parenchyma and premammary adipose tissue) in healthy women using ultrasound two-dimensional shear wave elastography (2D-SWE); 2) to reveal a possible correlation between increased stiffness of the breast parenchyma and hyperprolactinemia in patients with mastodynia and mastopathy; 3) to evaluate the ability of the Vitex agnus-castus drug to reduce the stiffness of the breast glandular tissue; 4) to objectify the ability of the Vitex agnus-castus drug to affect the thickness of the breast parenchyma, the condition of the milk ducts and cystic changes.
Materials and methods. Breast tissue stiffness was investigated using 2D shear wave elastography (2D-SWE) in 32 women aged 18–52 with cyclic mastalgia/mastopathy before and after treatment with Vitex agnus-castus drug. A correlation was made with laboratory parameters (prolactin level), the general condition of the breast according to the results of ultrasonography in gray scale mode. The control group consisted of 78 women without complaints, without signs of diffuse and focal pathology of the mammary glands.
Results. The 2D-SWE elastography showed normal values of breast tissue stiffness in women without pathology. 2D-SWE in symptomatic women made it possible to detect increased stiffness of the breast parenchyma, thereby screening for its diffuse changes. At the same time, dynamic changes in the softbreast tissue as a result of the treatment (parenchyma thickness, dilatation of the milk ducts, the presence of simple cystic foci (BI-RADS 2)) were diagnosed, analyzed and compared in grayscale mode ultrasonography (2D). The majority of patients (90,6%) noted a decrease in the level of prolactin after treatment. Statistical evidence of the positive effect of the Vitex agnus-castus drug in the treatment of mastodynia/mastopathy has been proven.
Conclusions. Assessment of the basic breast tissue stiffness using 2D-SWE makes it possible to screen patients with its elevated values. This fact makes it possible to assign these women to the risk group of developing breast cancer. Evaluation of changes in the mechanical stiffness properties of the breast soft tissues makes it possible to evaluate and objectify the effectiveness of the treatment.

Author Biographies

Z.M. Makarova, Medical Center “Doctor Lachman”, Zaporizhzhia

Gynecologist, ultrasound doctor, director

O.A. Fedusenko, Medical Center “Doctor Lachman”, Zaporizhzhia

PhD, associate professor, radiologist, sonologist

References

  1. Barannyk, E.O., Linska, H.V., Dynnyk, O.B., Marusenko, A.I. “Artifacts and methodological errors of shear wave elastography.” Radiation diagnostics, radiation therapy 1 (2015): 61–71.
  2. Dzeranova, L.K., Wax, V.V. Hyperprolactinemia in women and men: a guide for doctors. Moscow (2007): 57.
  3. Gromova, A.M., Gromova, A.L. “Peculiarities of gynecological examination of patients with macular diseases.” Obstet Gynecol 6 (2006): 39–40.
  4. Dynnyk, O.B., Fedusenko, A.A., Kobylyak, N.N., Lynskaya, A.V. “6 measurements of ultrasound diagnostics of diffuse liver diseases or multiparametric ultrasound.” Radiation diagnostics, radiation therapy 3–4 (2016): 69–84.
  5. Dynnik, O.B., Zhayvoronok, M.N., Kobylyak, N.M., Kharchenko, M.S. “Ultrasound elastography: theory and practice of the creation of a training simulator.” Radiation diagnostics, radiation therapy 3 (2014): 42–53.
  6. Zotov, A.S. Mastopathy and breast cancer. Moscow. MEDpress-inform (2005): 112.
  7. Kovalev, O.O. Cyclic mastalgia in women with non-neoplastic lesions of the mammary glands. Scientific and practical conference “Harmony of hormones. The basis of a woman’s reproductive health” (2021). Available from: [https://www.youtube.com/watch?v=kIn6ITt01ls], last accessed Mar 17, 2023.
  8. Korichensky, A.N., Babkina, T.M., Volik, N.K., Medvedev, V.E. “Elastography of the mammary gland: what determines the rigidity of tissues.” Radiation diagnostics, radiation therapy 2 (2018): 73–83.
  9. Ministry of Health of Ukraine. Order from 30.06.2015 № 396 “Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care. Breast cancer.”
  10. Vysotskaya, I.V., Letyagin, V.P., Kim, E.A., et al. “Practical recommendations for drug correction of diffuse dyshormonal dysplasia of the mammary glands” Tumors of the female reproductive system 2 (2014): 45–52.
  11. Radzinsky, V.E. Breast medicine and gynecological diseases. Moscow. StatusPraesens (2017): 352.
  12. Tatarchuk, T.F., Efimenko, O.A. Hyperprolactinemia as the cause of chronic breast diseases: specialized medical portal Health-ua.com. Available from: [https://health-ua.com/article/6010-giperprolaktinemiya-kak-prichina-dobrokachestvennyh-zabolevanij-molochnoj-z], last accessed Mar 17, 2023.
  13. Tronko, M.D., Antipkin, Y.G., Kaminskyi, V.V., et al. “National consensus on management of patients with hyperprolactinemia (2016).” Medical aspects of women’s health 1 (2017): 32–42.
  14. Ministry of Health of Ukraine. Order from № 1218 of July 13, 2022. Unified clinical protocol of primary and specialized medical care “Premenstrual syndrome”.
  15. Wang, A., Zhong, J., Wang, S., et al. “Different precompression does not reduce the diagnostic value of virtual touch tissue imaging and quantification (VTIQ) in breast lesions, especially for the ratio of the shear wave velocity between lesions and surrounding tissues.” Eur J Radiology 151 (2022): 110284.
  16. Alhabshi, S.M., Rahmat, K., Abdul Halim, N., et al. “Semi-quantitative and qualitative assessment of breast ultrasound elastography in differentiating between malignant and benign lesions.” Ultrasound Med Biol 39 (2013): 568–78.
  17. Athanasiou, A., Tardivon, A., Tanter, M., et al. “Breast Lesions: Quantitative Elastography with Supersonic Shear Imaging – Preliminary Results.” Radiology 256 (2010): 297–303.
  18. Barr, R.G. “Breast Elastography: How to Perform and Integrate into “Best Practice” Patient Management Algorithm.” J Ultrasound Med 39.1 (2020): 7–17.
  19. Barr, R.G., Zhang, Z. “Shear-wave elastography of the breast: value of quality measure and comparison with strain elastograph.” Radiology 275 (2015): 45–53.
  20. Barr, R.G., Zhang, Z. “Effects of precompression on elasticity imaging of the breast: Development of a clinically useful semiquantitative method of precompression assessment.” J Ultrasound Med 31 (2012): 895–902.
  21. Hartmann, L.C., Sellers, T.A., Frost, M.H., et al. “Benign Breast Disease and the Risk of Breast Cancer.” N Engl J Med 353 (2005): 229–37.
  22. Bojanic, K., Katavic, N., Smolic, M., et al. “Implementation of Elastography Score and Strain Ratio in Combination with B-Mode Ultrasound Avoids Unnecessary Biopsies of Breast Lesions.” Ultrasound Med Biol 43 (2017): 804–16.
  23. Butcher, D.T., Alliston, T., Weaver, V.M. “A tense situation: forcing tumour progression.” Nat Rev Cancer 9.2 (2009): 108–22.
  24. Cantisani, V., David, E., Barr, R.G., et al. US-Elastography for Breast Lesion Characterization: Prospective Comparison of US BIRADS, Strain Elastography and Shear wave Elastography. Ultraschall Med 42.05 (2021): 533–40.
  25. Fang, M., Yuan, J., Peng, C., et al. “Collagen as a double-edged sword in tumor progression.” Tumour Biology 35.4 (2014): 2871–82.
  26. American College of Obstetricians and Gynecologists. Committee Opinion No. 625. “Management of Women With Dense Breasts Diagnosed by Mammography.” Obstet Gynecol 125 (2015): 750–1.
  27. Dekkers, O.M., Ehrenstein, V., Bengtsen, M., et al. “Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature.” Eur J Endocrinol 17.2 (2015): 269–73.
  28. Dobruch-Sobchak, K., Nowitcki, A. “Role of Shear Wave Sonoelastography in Differentiation Between Focal Breast Lesions.” Ultrasound Med Biol 41.2 (2015): 366–74.
  29. Dominkovic, M.D., Ivanac, G., Bojanic, K., et al. “Exploring Association of Breast Pain, Pregnancy, and Body Mass Index with Breast Tissue Elasticity in Healthy Women: Glandular and Fat Differences.” Diagnostics 10.6 (2020): 393.
  30. Bamber, J., Cosgrove, D., Dietrich, C.F., et al. “EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology.” Ultraschall Med 34.2 (2013): 169–84.
  31. Rzymski, P., Skórzewska, A., Skibińska-Zielińska, M., et al. “Factors influencing breast elasticity measured by the ultrasound Shear Wave elastography – preliminary results.” Arch Med Sci 7.1 (2011): 127–33.
  32. Faruk, T., Islam, M.K., Arefin, S., et al. “The Journey of Elastography: Background, Current Status and Future Possibilities in Breast Cancer Diagnosis.” Clinical Breast Cancer 15 (2015): 313–24.
  33. Ferlay, J., Soerjomataram, I., Dikshit, R., et al. “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.” Int J Cancer (Oct 9, 2014). Available from: [https://www.iarc.who.int/news-events/cancer-incidence-and-mortality-worldwide-sources-methods-and-major-patterns-in-globocan-2012/].
  34. Gefen, A., Dilmoney, B. “Mechanics of the normal woman’s breast.” Technol Health Care 15 (2007): 259–71.
  35. Hallberg, Ö., Johansson, O. “Sleep on the right side – Get cancer on the left?” Pathophysiology 17 (2010): 157–60.
  36. Csupor, D., Lantos, T., Hegyi, P., et al. “Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials.” Complement Ther Med 47 (2019): 102190. DOI: 10.1016/j.ctim.2019.08.024
  37. Kaiser, U.B. “Hyperprolactinemia and infertility: new insights.” J Clin Invest 122.10 (2012): 3467–8.
  38. Murshid, K.R. “A Review of Mastalgia in Patients with Fibrocystic Breast Changes the Non-Surgical Treatment Options.” Journal of Taibah University Medical Sciences 6.1 (2011): 1–18.
  39. Krouskop, T.A., Wheeler, T.M., Kallel, F., et al. “Elastic moduli of breast and prostate tissues under compression.” Ultrason Imaging 20 (1998): 260–74.
  40. Choi, L. Breast Cancer. MSD Manual. Professional Version. Available from: [https://msdmanuals.com/professional/gynecology-and-obstetrics/breast-disorders/breast-cancer], last accessed Sep 2022.
  41. Wang, J., Costantino, J.P., Tan-Chiu, E., et al. “Lower-Category Benign Breast Disease and the Risk of Invasive Breast Cancer.” JNCI 96.8 (2004): 616–20.
  42. Boyd, N.F., Rommens, J.M., Vogt, K., et al. “Mammographic breast density as an intermediate phenotype for breast cancer.” Lancet Oncol 6.10 (2005): 798–808.
  43. Chin, L., Xia, Y., Discher, D.E., et al. “Mechanotransduction in cancer.” Curr Opin Chem Eng 11 (2016): 77–84.
  44. Mendes, C., Fonseca, A.M.D., Alves, M.S., et al. “Narrative review of Vitex agnus-castus in symptoms in Gynecology.” Rev Assoc Med Bras (1992) 68.5 (2022): 716–9.
  45. Patel, B.K., Pepin, K., Brandt, K.R., et al. “Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE).” Breast Cancer Res Treat 194.1 (2022): 79–89.
  46. Plu-Bureau, G., Lê ,M.G., Sitruk-Ware, R., et al. “Cyclical mastalgia and breast cancer risk Results of a French cohort study.” Cancer Epidemiol Biomarcers Prev 15.6 (2006): 1229–31.
  47. Radiology Key. Elastography of the Breast. WordPress theme by UFO themes. Available from: [https://radiologykey.com/elastography-of-the-breast-2/], last accessed Jul 9, 2018.
  48. Rzymski, P., Skórzewska, A., Opala, T. “Changes in ultrasound shear wave elastography properties of normal breast during menstrual cycle.” Clin Exp Obstet Gynecol 38 (2011): 137–42.
  49. Rzymski, P., Wysocki, P., Kycler, W., et al. “Correlation between insulin resistance and breast elasticity heterogeneity measured by shear wave elastography in premenopausal women – A pilot study.” Arch Med Sci 7 (2011): 1017–22.
  50. Seo, M., Ahn, H.S., Park, S.H., et al. “Comparison and Combination of Strain and Shear Wave Elastography of Breast Masses for Differentiation of Benign and Malignant Lesions by Quantitative Assessment: Preliminary Study.” J Ultrasound Med 37 (2018): 99–109.
  51. Taljanovich, M.S., Gimbert, L.H., Becker, G.W., et al. “Shear-Wave Elastography: Basic Physics and Musculoskeletal Applications.” RadioGraphics 37 (2017): 855–70.
  52. Tanter, M., Bercoff, J., Athanasiou, A., et al. “Quantitative Assessment of Breast Lesion Viscoelasticity: Initial Clinical Results Using Supersonic Shear Imaging.” Ultrasound Med Biol 34 (2008): 1373–86.
  53. Săftoiu, A., Gilja, O.H., Sidhu, P.S., et al. “The EFSUMB Guidelines and Recommendations for the Clinical Practice of Elastography in Non-Hepatic Applications: Update 2018.” Ultraschall in Med 40.04 (2019): 425–53.
  54. Vashi, R., Hooley, R., Butler, D., et al. “Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer.” Am J Roentgenol 200.2 (2013): 321–8.
  55. Barr, R.G., Nakashima, K., Amy, D., et al. “WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast.” Ultrasound Med Biol 41.5 (2015): 1148–60.
  56. Wojcinski, S., Brandhorst, K., Sadigh, G., et al. “Acoustic radiation force impulse imaging with virtual touch tissue quantification: measurements of normal breast tissue and dependence on the degree of pre-compression.” Ultrasound Med Biol 39.12 (2013): 2226–32.
  57. Wang, X., Hu, Y., Zhu, J., et al. “Effect of acquisition depth and precompression from probe and couplant on shear wave elastography in soft tissue: an in vitro and in vivo study.” Quant Imaging Med Surg 10.3 (2020): 754–65.

Downloads

Published

2023-03-31

How to Cite

Makarova, Z., & Fedusenko, O. (2023). Possibilities of multi-parameter ultrasonography in diagnostic and evaluation of Vitex agnus-castus treatment of patients with mastodynia and mastopathy. REPRODUCTIVE ENDOCRINOLOGY, (67), 47–54. https://doi.org/10.18370/2309-4117.2023.67.47-54

Issue

No. 67 (2023)

Section

Tumors and pretumoral pathology

License

Copyright (c) 2023 Ж.М. Макарова, О.А. Федусенко

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.